ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity.

Alexandra J Brownstein, Michaela Veliova, Rebeca Acin-Perez, Marc Liesa, Orian S Shirihai

Journal: Reviews in endocrine & metabolic disorders 2022;23(1):121-131

PMID: 34741717

Abstract

Obesity results from an imbalance in energy homeostasis, whereby excessive energy intake exceeds caloric expenditure. Energy can be dissipated out of an organism by producing heat (thermogenesis), explaining the long-standing interest in exploiting thermogenic processes to counteract obesity. Mitochondrial uncoupling is a process that expends energy by oxidizing nutrients to produce heat, instead of ATP synthesis. Energy can also be dissipated through mechanisms that do not involve mitochondrial uncoupling. Such mechanisms include futile cycles described as metabolic reactions that consume ATP to produce a product from a substrate but then converting the product back into the original substrate, releasing the energy as heat. Energy dissipation driven by cellular ATP demand can be regulated by adjusting the speed and number of futile cycles. Energy consuming futile cycles that are reviewed here are lipolysis/fatty acid re-esterification cycle, creatine/phosphocreatine cycle, and the SERCA-mediated calcium import and export cycle. Their reliance on ATP emphasizes that mitochondrial oxidative function coupled to ATP synthesis, and not just uncoupling, can play a role in thermogenic energy dissipation. Here, we review ATP consuming futile cycles, the evidence for their function in humans, and their potential employment as a strategy to dissipate energy and counteract obesity.

© 2021. The Author(s).

Address: Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Molecular Cellular Integrative Physiology Interdepartmental Program, University of California, Los Angeles, CA, 90095, USA.; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Department of Medicine, Division of Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.; Molecular Biology Institute, University of California, Los Angeles, CA, 90095, USA.; Metabolism Theme, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. [email protected].; Molecular Cellular Integrative Physiology Interdepartmental Program, University of California, Los Angeles, CA, 90095, USA. [email protected].; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. [email protected].; Department of Medicine, Division of Endocrinology, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.